ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 609

$1.01M Total Retail Price of All Prescriptions

Rank: 21 out of 609

646 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 646 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

4% of this provider’s 646 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,694 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 431 387 1 2
OMEPRAZOLE 407 330 2 3
ZOLPIDEM TARTRATE 295 198 3 18
METFORMIN HCL 291 201 4 10
DIOVAN 269 219 5 15
METOPROLOL SUCCINATE 265 202 6 5
CRESTOR 253 207 7 16
FLUTICASONE PROPIONATE 239 204 8 52
PRAVASTATIN SODIUM 236 167 9 35
FUROSEMIDE 230 201 10 4
JANUVIA 229 221 11 34
ATORVASTATIN CALCIUM 204 176 12 6
LISINOPRIL 191 169 13 12
ADVAIR DISKUS 180 111 14 28
NAMENDA 180 176 14 36
LOSARTAN POTASSIUM 173 144 16 24
CLOPIDOGREL 170 142 17 17
TAMSULOSIN HCL 153 124 18 11
HYDROCHLOROTHIAZIDE 153 140 18 20
LEVOTHYROXINE SODIUM 152 122 20 7
CARVEDILOL 146 123 21 14
PROAIR HFA 137 95 22 57
IBUPROFEN 136 91 23 103
PLAVIX 135 120 24 25
SIMVASTATIN 133 109 25 1
TRAMADOL HCL-ACETAMINOPHEN 130 96 26 102
ALENDRONATE SODIUM 130 122 26 54
NEXIUM 130 96 26 13
DONEPEZIL HCL 127 126 29 22
ATELVIA 126 103 30 188
AMLODIPINE BESYLATE-BENAZEPRIL 124 106 31 88
PANTOPRAZOLE SODIUM 120 106 32 29
ENALAPRIL MALEATE 119 79 33 32
CLOTRIMAZOLE-BETAMETHASONE 109 97 34 135
WARFARIN SODIUM 105 105 35 8
CELEBREX 102 95 36 60
SPIRIVA 91 57 37 43
FEXOFENADINE HCL 91 67 37 328
SINGULAIR 91 75 37 78
POLYETHYLENE GLYCOL 3350 89 81 40 99
MELOXICAM 86 73 41 55
BENICAR 85 76 42 198
MECLIZINE HCL 84 76 43 144
NAPROXEN 82 56 44 98
ATENOLOL 81 75 45 27
METOPROLOL TARTRATE 77 58 46 9
GABAPENTIN 74 60 47 21
RAMIPRIL 72 57 48 46
AMMONIUM LACTATE 71 65 49 192
EXELON 68 68 50 142
PAROXETINE HCL 67 54 51 123
AZITHROMYCIN 65 51 52 67
ACTOS 63 58 53 145
AZOR 62 55 54 330
ACETAMINOPHEN-CODEINE 62 50 S3 54 136
PROCTOZONE-HC 61 45 56 249
ULTICARE 58 31 57 454
DIOVAN HCT 58 47 57 31
KETOCONAZOLE 57 51 59 118
GLIMEPIRIDE 56 42 60 53
NIFEDIPINE ER 56 38 60 230
LIDODERM 53 48 62 81
GLIPIZIDE 52 43 63 169
LEVOCETIRIZINE DIHYDROCHLORIDE 51 45 64 244
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.